Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
The primary objective of this study is to evaluate the impact of substance abuse treatment as usual plus smoking cessation treatment (TAU+SCT), relative to substance abuse treatment as usual (TAU), on drug abuse outcomes. The study will evaluate whether concurrent smoking cessation treatment improves, worsens, or has no effect on drug abuse outcomes in smokers who are in outpatient substance abuse treatment for cocaine or methamphetamine dependence. Secondary objectives include evaluating: 1) the efficacy of TAU+SCT, relative to TAU, in improving smoking outcomes; 2) the safety of TAU+SCT relative to TAU.
- Gibson Recovery Center, Inc., Missouri
- Maryhaven, Inc., Ohio
- Western Psychiatric Institute and Clinic (WPIC), Pennsylvania
- Gateway Health Systems, Florida
- Matrix Institute on Addictions, California
- Tarzana Treatment Center, California
- Behavioral Health Services of Pickens County, South Carolina
- Dorchester Alcohol and Drug Commission, South Carolina
- Lexington/Richland Alcohol and Drug Abuse Council, South Carolina
- Nexus Recovery Center, Inc., Texas
- ADAPT, Inc., Oregon
- La Frontera Center, Inc., Arizona
Get this Publication
Formed with SAMHSA to reduce the gap between research results and treatment.